To give is better than to receive: Compliance with WHO guidelines for drug donations during 2000-2008

Bulletin of the World Health Organization

Volumn 88, Issue 12, 2010, Pages 922-929

  Bero, Lisa ^a   Carson, Brittany ^b   Moller, Helene ^c   Hill, Suzanne ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Molecular Biology and Genetics   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AID FLOW; DRUGS TRADE; GUIDELINE; HEALTH CARE; MONITORING; WORLD HEALTH ORGANIZATION;

ARTICLE; DISASTER; DRUG DONATION; DRUG INFORMATION; DRUG LABELING; DRUG PACKAGING; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HUMAN; INTERNET; MEDICAL LITERATURE; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; QUALITY CONTROL; SHELF LIFE; WORLD HEALTH ORGANIZATION;

DISASTERS; DRUG INDUSTRY; GUIDELINE ADHERENCE; INTERNATIONAL COOPERATION; PHARMACEUTICAL PREPARATIONS; RELIEF WORK; WORLD HEALTH ORGANIZATION;

EID: 78649782730     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.10.079764     Document Type: Article

References (29)

1. Hogerzeil HV, Couper MR, Gray R. Guidelines for drug donations. BMJ 1997;314:737-740. PMID:9116555
2. Guidelines for drug donations. Geneva: World Health Organization; 1999. (WHO/EDM/PAR/99.4). Available from: http://apps.who.int/medicinedocs/ en/d/Jwhozip52e/5.1.html [accessed 5 August 2010].
3. Autier P, Govindaraj R, Gray R, Lakshminayaranan R, Nassery HG, Schmets G. Drug donations in post-emergency situations. Washington: The International Bank for Reconstruction and Development; 2002. (Health Nutrition and Population discussion paper).
4. Mariacher GG, Mtasiwa D, Wiedenmayer K, Bruppacher R, Tanner M, Hersberger KE. Optimizing in-kind drug donations for Tanzania-a case study. Int J Health Plann Manage 2008;23:313-344. doi:10.1002/hpm.901 PMID:17803256
5. Evaluation of UNICEF emergency preparedness and early response in Iraq, September 2001-June 2003: evaluation report 2004. New York: United Nations Children's Fund; 2004. Available from: http://www.unicef.org/ evaldatabase/fles/Iraq_evaluation_FINAL_2006.pdf [accessed 9 September 2008].
6. IHP and the UK's response to the JAVA earthquake - July 2006. Wadhurst: International Health Partners; 2006. Available from: http://www.ihpuk.org/ourservices/java.htm [accessed 9 March 2010].
7. Benaragamama BVSH, Fernandopulle R. The expectations, the reality and the burden of drug donation. Sri Lanka: Ministry of Healthcare and Nutrition & Faculty of Medicine, University of Colombo; 2007.
8. The study on drug donations in the province of Aceh in Indonesia. Bordeaux: Pharmaciens Sans Frontières Comité International; 2005. Available from: http://www.acfd.asn.au/what-we-do/docs_what-we-do/docs_humanitarian-and-emergencies/docs_tsunami/drugdonationsaceh.pdf [accessed 3 September 2010].
9. Parker V. Drug donations, not a dumping ground [editorial]. Pharm J 2005;274:2. Available from: http://www.pharmj.com/Editorial/20050108/ comment/lett01.html accessed 9 April 2008.
10. Wallerstein C. Unusable medicines "dumped" on Venezuela. BMJ 2000;320:1491. PMID:10834876
11. Strom S, Fleischer-Black M. Company's vow to donate a cancer drug falls short. New York Times 2003 June 5. Available from: http://www.nytimes. com/2003/06/05/business/05DRUG.html?ex=1221192000&en=1f87f362d 3c4148e&ei=5070 [accessed 10 September 2008].
12. Citizenship@Novartis [Internet]. Fighting leprosy. Basel: Novartis; 2010. Available from: http://www.corporatecitizenship.novartis.com/patients/access-medicines/access-in-practice/leprosy-publications.shtml [accessed 14 August 2010].
13. Novartis Foundation for Sustainable Development [Internet]. Q&A about the Novartis MDT leprosy donation. Basel: Novartis; 2010. Available from: http:// www.novartisfoundation.org/page/content/index.asp?MenuID=364&ID=1010 &Menu=3&Item=43.2.4 [accessed 14 August 2010].
14. Shretta R, Brugha R, Robb A, Snow RW. Sustainability, affordability, and equity of corporate drug donations: the case of Malarone. Lancet 2000;355:1718-1720. doi:10.1016/S0140-6736(00)02251-0 PMID:10905260
15. Alleman MM, Twum-Danso NAY, Thylefors BI. The Mectizan Donation Program - highlights from 2005. Filaria J 2006;5:11. doi:10.1186/1475-2883-5-11 PMID:17005039
16. WHO model list of essential medicines. Geneva: World Health Organization; 2009. Available from: http://www.who.int/selection_medicines/committees/expert/17/sixteenth_adult_list_en.pdf [accessed 25 August 2010].
17. Oyediran ABO, Ddumba EM, Ochola SA, Lucas AO, Koporc K, Dowdle WR. A public-private partnership for malaria control: lessons from the Malarone Donation Programme. Bull World Health Organ 2002;80:817-821. PMID:12471403
18. Stephens J. Panel faults Pfizer in '96 clinical trial in Nigeria. The Washington Post. 2006 May 7; Sect A:1. Available from: http://www.washingtonpost.com/ wpdyn/content/article/2006/05/06/AR2006050601338.html. [accessed 28 August 2006].
19. Thylefors B, Alleman MM, Twum-Danso NAY. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis. Trop Med Int Health 2008;13:689-696. doi:10.1111/j.1365-3156.2008.02049.x PMID:18419585
20. Richards FO Jr, Boatin B, Sauerbrey M, Sékétéli A. Control of onchocerciasis today: status and challenges. Trends Parasitol 2001;17:558-563. doi:10.1016/S1471-4922(01)02112-2 PMID:11756018
21. Novartis [Internet]. History of Glivec in India. Basel: Novartis; 2010. Available from: http://www.novartis.com/downloads/about-novartis/glivec-history-india. pdf. [accessed 14 August 2010].
22. An open letter from Novartis regarding the Glivec legal challenge in India: why Novartis thinks improving patent law will beneft patients and society. Basel: Novartis; 2007. Available from: http://www.cptech.org/ip/health/c/india/ novartis_open_letter.pdf. [accessed 10 September 2008].
23. Huff B. Recycling HIV drugs: exporting medicine, experience, and hope. In: The body, the complete AIDS resource [Internet]. New York: Body Health Resources Corporation. Available from: http://www.thebody.com/content/ art13570.html [accessed 14 August 2010].
24. Pomerantz JM. Recycling expensive medication: why not? Med GenMed 2004;6:4. PMID:15266231
25. Ernde L. Program to recycle surplus medicine. Oakland Tribune. 2006 Feb 23. Available from: http://fndarticles.com/p/articles/mi_qn4176/ is_20060223/ai_n16175625/print?tag=artBody;col1. [accessed 9 February 2010].
26. Donation of medicines eligibility program. Gatineau: Canadian International Development Agency; 2009. Available from: http://www.acdi-cida.gc.ca/acdi-cida/acdi-cida.nsf/eng/JUD-62594147-J3N. [accessed 10 March 2010].
27. Be a better donor: practical recommendations for humanitarian aid. Clayton: Pan American Health Organization; 2009. Available from: www.saberdonar. info. [accessed 20 January 2010].
28. Lucas AO. Public-private partnerships: illustrative examples. In: Reich M, ed. Public private partnerships for public health. Cambridge: Harvard University Press; 2002. pp. 19-40.
29. Medical equipment in Gaza hospitals. Geneva: World Health Organization; 2009.